A “bridging” (safety/tolerance) study of Besipirdine Hydrochloride in patients with Alzheimer's disease
- 11 August 1995
- journal article
- clinical trial
- Published by Elsevier in Life Sciences
- Vol. 57 (12) , 1241-1248
- https://doi.org/10.1016/0024-3205(95)02068-t
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- A multiple-dose safety trial of eptastigmine in Alzheimer's disease, with pharmacodynamic observations of red blood cell cholinesteraseLife Sciences, 1994
- Clinical Safety, Tolerance, and Plasma Levels of the Oral Anticholinesterase 1,2,3,4-Tetrahydro-9-aminoacridin-1-oL-maleate (HP 029) in Alzheimer's Disease: Preliminary FindingsThe Journal of Clinical Pharmacology, 1990
- Oral Tetrahydroaminoacridine in Long-Term Treatment of Senile Dementia, Alzheimer TypeNew England Journal of Medicine, 1986
- Alzheimer's DiseaseNew England Journal of Medicine, 1986
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984
- Alzheimer's Disease: A Disorder of Cortical Cholinergic InnervationScience, 1983
- Alzheimer's Disease and Senile Dementia: Loss of Neurons in the Basal ForebrainScience, 1982
- Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia.BMJ, 1978
- SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASEPublished by Elsevier ,1976
- “Mini-mental state”Journal of Psychiatric Research, 1975